Status:
RECRUITING
Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients
Lead Sponsor:
Mansoura University
Conditions:
Kidney Failure,Chronic
Anemia in End Stage Renal Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
People with severe kidney failure who need regular hemodialysis treatment often experience several health problems. These include anemia (low red blood cell count), issues with their bone health (some...
Detailed Description
Background: Chronic kidney disease (CKD) is a major global health issue. Renal anemia is a frequent and significant complication, affecting over 90% of patients with end-stage kidney disease (ESKD) r...
Eligibility Criteria
Inclusion
- The age of the patient is more than 18.
- Patients who are willing to sign informed consent.
- Patients with ESKD on chronic hemodialysis for more than 3 months.
Exclusion
- Current pregnancy or lactation.
- Patients with pre-existing malignancy.
- patients with psychosis.
- Known history of hematological disorders or other causes of anemia other than CKD.
- Taking medications that may significantly affect or interact with bone metabolism such as osteo-anabolics or bone resorptives during the last 6 months.
Key Trial Info
Start Date :
April 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT06917950
Start Date
April 15 2025
End Date
November 1 2025
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology and Nephrology Center, Mansoura University
Al Mansurah, Dakahliya, Egypt, 35111